SubjectWell, provider of the most accurate, diverse, predictable and patient-centric patient recruitment platform, is pleased to announce its acquisition of Trials24, a renowned provider of global digital patient recruitment solutions. This strategic acquisition will enhance SubjectWell’s ability to connect patients to transformative healthcare across all geographies.
The integration of Trials24 into SubjectWell’s operations brings together two industry leaders who share a deep commitment to improving global healthcare. Trials24, with its cutting-edge technology, digital marketing expertise, and engagement centre with local native language representatives in more than 13 European countries, joins forces with SubjectWell’s Patient Network of over 13 million patients interested in pursuing new treatments, including six million people of colour. With an innovative solution to patient engagement, retention and fulfilment, SubjectWell is the only partner capable of delivering excellence in global patient recruitment.
“This acquisition is an exciting new chapter for SubjectWell,” said Fred Martin, chief executive officer of SubjectWell. “By combining our strengths with those of Trials24, we are poised to set a new standard in patient recruitment. Together, we will expand our global reach, drive diversity in clinical trials, and offer unparalleled technology suite and services to our clients. More importantly, we will improve access to clinical trials for patients everywhere, ushering in a new era of effective and inclusive clinical research.”
“We are thrilled to join forces with SubjectWell,” said Dr Tobias Kruse, chief executive officer of Trials24. “Our shared vision of improving patient access to clinical trials aligns perfectly, and we are excited about the opportunities this new chapter presents. Together, we will have the largest reach of patients and engagement centres to support all global studies.”
SubjectWell and Trials24 have already begun integrating their businesses. The transition will not impact any customer or patient engagements.